PolySciTech Products In Literature
PLGA-Rhodamine from PolySciTech used in research on SiRNA delivery as part of cystic fibrosis treatment development
Cystic Fibrosis is a severe and fatal lung disease that can potentially be treated by delivery of SiRNA to modify the way in which the lung fluids behave. Recently, researchers at Ludwig-Maximilians-Universität (Germany), the University of Campania Luigi Vanvitelli, the University of Milano, the University of Napoli Frederico II, and Children’s Hospital Bambino Gesu (Italy) used PLGA-Rhodamine (AV011) from PolySciTech to fluorescently label and track nanoparticles for an inhaled therapy application. This research holds promise to improve treatment against a wide variety of lung diseases. Read more: Conte, Gemma, Gabriella Costabile, Domizia Baldassi, Valeria Rondelli, Rosaria Bassi, Diego Colombo, Giulia Linardos et al. "Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?." ACS Applied Materials & Interfaces (2022).
|
|
Print what you want with the latest bioresorbable polymer technology. AKiNAfil™ bioresorbable PLGA polymers reformatted in standardized 1.7 mm filament are available in a variety of lengths. The PLGA polymers are co-formulated with FDA-GRAS and biocompatible acetyltriethylcitrate (ATEC) plasticizer for improved processability and biorelevant degradation properties to be used in a wide array of biomedical applications. |
|
|
Browse through our searchable list of research
that reference the use of PolySciTech products.
|
|
|
PolySciTech Division of Akina, Inc. (www.polyscitech.com) provides a wide array of biodegradable polymers and other research supplies. Visit our website to find out more.
|
|
|
|
